does tirzepatide cause heart palpitations TrimRX A Man's Rapid Weight Loss

The Long COVID Treatment Trial-Tirzepatide (LoCITT-T) is investigating the efficacy of repurposing this drug to treat Long COVID

*In a 72-week study of adults without diabetes, average weight loss was 15.0% (34 lbs) for 5mg, 19.5% (44 lbs) for 10mg, 20.9% (48 lbs) for 15 mg, and 3.1 (7 lbs) for placebo

Always talk to your healthcare provider if you have side effects or worries while using this medicine

Notably, the research also demonstrates that TZP can synergize with standard chemotherapeutic agents, such as oxaliplatin, 5-fluorouracil (5-FU), and SN-38, potentially enhancing efficacy while reducing treatment toxicity